Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.6K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating osteocalcin: A potential predictor of ketosis in type 2 diabetes.

Diabetes/metabolism research and reviews·2019
Same author

Provincial and sector-level material footprints in China.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same author

Functionalized selenium nanoparticles for targeted siRNA delivery silence Derlin1 and promote antitumor efficacy against cervical cancer.

Drug delivery·2019
Same author

Long non-coding RNA RNCR3 promotes glioma progression involving the Akt/GSK-3β pathway.

Oncology letters·2019
Same author

Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.

Materials science & engineering. C, Materials for biological applications·2019
Same author

Functionalization of Silver Nanoparticles Loaded with Paclitaxel-induced A549 Cells Apoptosis Through ROS-Mediated Signaling Pathways

Current topics in medicinal chemistry·2019

Related Experiment Video

Updated: Jul 2, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

Transcriptomics analysis revealed that TAZ regulates the proliferation of KIRC cells through mitophagy.

Zhen He1,2, Jianxi Shi1, Bing Zhu1

  • 1Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China.

BMC Cancer
|February 19, 2024
PubMed
Summary
This summary is machine-generated.

Transcriptional Co-Activator with PDZ-Binding Motif (TAZ) promotes kidney cancer (KIRC) by inhibiting mitophagy. High TAZ expression correlates with poor KIRC prognosis, suggesting TAZ as a potential therapeutic target.

Keywords:
MitophagyRenal clear cell carcinoma (KIRC)The Cancer Genome Atlas (TCGA)Transcriptional co-activator with PDZ-Binding motif (TAZ)

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.1K
In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice
08:40

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

17.6K

Related Experiment Videos

Last Updated: Jul 2, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.1K
In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice
08:40

In Vitro and In Vivo Detection of Mitophagy in Human Cells, C. Elegans, and Mice

Published on: November 22, 2017

17.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Transcriptional Co-Activator with PDZ-Binding Motif (TAZ) is a Hippo pathway effector regulating cell growth and differentiation.
  • TAZ is implicated in tumor promotion across various cancers and its role in mitophagy is under investigation.
  • The specific function and molecular mechanisms of TAZ in renal clear cell carcinoma (KIRC) remain largely undefined.

Purpose of the Study:

  • To investigate the role and molecular mechanisms of TAZ in KIRC.
  • To analyze the correlation between TAZ expression, clinical data, and mitophagy in KIRC patients.
  • To determine if TAZ can serve as a potential therapeutic target for KIRC.

Main Methods:

  • Systematic analysis of mRNA expression profiles and clinical data from The Cancer Genome Atlas (TCGA) dataset for KIRC.
  • Joint analysis of TAZ expression with 36 mitophagy-related genes in KIRC.
  • Correlation analysis between TAZ expression levels and patient prognosis.

Main Results:

  • TAZ mRNA expression is significantly upregulated in KIRC tissues compared to normal kidney tissues.
  • High TAZ expression is significantly associated with poor patient prognosis in KIRC.
  • TAZ expression shows a significant negative correlation with positive regulators of mitophagy, indicating TAZ inhibits mitophagy.
  • High TAZ expression suppresses mitophagy and promotes KIRC cell proliferation.

Conclusions:

  • TAZ plays a significant role in the progression of KIRC.
  • TAZ functions by inhibiting mitophagy and promoting KIRC cell proliferation.
  • TAZ represents a potential novel therapeutic target for KIRC treatment.